| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | D05AX01 |
| UNII: | 88XHZ13131 |
Structure
| InChI Key | VZCYOOQTPOCHFL-OWOJBTEDSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C4H4O4 |
| Molecular Weight | 116.07 |
| AlogP | -0.29 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 74.6 |
| Molecular species | ACID |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 8.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | 19000 | - | - | 25 | |
|
Enzyme
|
- | 19000 | - | - | 10 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Psoriasis | 4 | D011565 | ClinicalTrials |
| Lupus Erythematosus, Cutaneous | 2 | D008178 | ClinicalTrials |
Related Entries
MCS
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 110-17-8 |
| ChEBI | 18012 |
| ChEMBL | CHEMBL503160 |
| DrugBank | DB01677 |
| DrugCentral | 3229 |
| EPA CompTox | DTXSID3021518 |
| FDA SRS | 88XHZ13131 |
| Human Metabolome Database | HMDB0000176 |
| KEGG | C00122 |
| PDB | FUM |
| PubChem | 444972 |
| SureChEMBL | SCHEMBL1177 |
| ZINC | ZINC000003860193 |
CONTENTS